Navigation Links
Hot new manufacturing tool: A temperature-controlled microbe
Date:4/16/2012

it when P. furiosus is out in the cold at 72C. This essentially gives scientists a switch for controlling lactate production: put the organism at 72C to turn on lactate production, restore it to 100C to turn it off, thus preventing the need for chemical inducers. What's more, since P. furiosus is mostly shut down at these lower temperatures, making the new product doesn't interfere with its metabolism, or vice-versa.

The lead author on the study, Michael Adams of the Department of Biochemistry & Molecular Biology at the University of Georgia, explains that this is the key benefit of this system: although P. furiosus now makes the enzyme that carries out the process, at these lower temperatures the organism's other metabolic processes don't get in the way.

"The hyperthermophile is essentially the bioreactor that contains the foreign enzymes," says Adams. P. furiosus just supplies cofactors and a cytoplasmic environment for the highly active foreign enzymes, according to Adams. This makes for a cleaner, more controllable reaction.


'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1 2

Related biology news :

1. The shape of things to come: NIST probes the promise of nanomanufacturing using DNA origami
2. Manufacturing microscale medical devices for faster tissue engineering
3. New process for manufacturing nanocellulose recognized with the Empa Research Award
4. Reportlinker Adds Enzymes in Drug Manufacturing
5. Advance in microchannel manufacturing opens new industry applications
6. Discovery of source of glycogen manufacturing errors sheds light on fatal disease
7. Fly eye paves the way for manufacturing biomimetic surfaces
8. Semiconductor Manufacturing International Corporation: Announcement of 2009 Annual Results
9. Manufacturing antibodies
10. Louisiana Techs Institute for Micromanufacturing to collaborate with colleagues in the arts
11. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... Start-up awarded with an additional 100.000 Euros in financial ... opportunity to double the financial support through the execution ... 4th edition of the Building Global Innovators & continued ... 3rd edition of Building Global Innovators Venture Competition. The ...
... findings published in Pediatrics (Epub ahead of print) ... Disorders reveal that 70 percent of children with autism spectrum ... achieved phrase or fluent speech by age eight. This suggests ... at age four can be expected to make notable language ...
... perform only one job, but a new study by a ... recruit enzymes for other jobs to benefit medical fields and ... function in a cell, but many are capable of doing ... the beginning of a chemical reaction that they don,t ...
Cached Biology News:Veniam is the winner of the major Portuguese Venture Competition 'Builidng Global Innovators' 2Veniam is the winner of the major Portuguese Venture Competition 'Builidng Global Innovators' 3Veniam is the winner of the major Portuguese Venture Competition 'Builidng Global Innovators' 4Speech emerges in children with autism and severe language delay at greater rate than thought 2Speech emerges in children with autism and severe language delay at greater rate than thought 3Promiscuous enzymes may be recruited to aid industry, medical fields 2
(Date:6/2/2015)... HONG KONG , June 2, 2015 /PRNewswire/ -- China Cord ... "us" and "our"), China,s leading provider ... and stem cell storage services, today announced that the Special ... has appointed Houlihan Lokey ( China ... Steen & Hamilton LLP as its United ...
(Date:6/2/2015)... German-based Moenninghoff has designated the R.M. Hoffman Company ... Moenninghoff product line . , Moenninghoff President ... the R.M. Hoffman Company will be representing Moenninghoff in ... this is a strategically important step. We are ... distributor we need to successfully grow our business in ...
(Date:6/1/2015)... YONGIN, South Korea , June 1, ... Green Cross Biotherapeutics Inc. (GCBT) kicked off construction today ... the Montreal Technoparc,s Saint-Laurent Campus. The CA$315 million project ... in Canada in the biopharmaceutical ... intravenous immunoglobulin (IVIG) and albumin manufacturing plant in ...
(Date:6/1/2015)... 1, 2015  Novartis is highlighting data from ... an investigational chimeric antigen receptor (CAR) T cell ... of specific types of hard-to-treat non-Hodgkin lymphoma. Findings ... of Pennsylvania,s Perelman School of Medicine (Penn) in ... B-cell lymphoma (DLBCL) and follicular lymphoma (FL) found ...
Breaking Biology Technology:China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 2Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 3Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 4Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 5Novartis highlights CTL019 data showing its potential in the treatment of specific types of hard-to-treat non-Hodgkin lymphoma 6
... Foundation for Angelman Syndrome Therapeutics (FAST) announces it will ... treatment for the rare genetic disorder, Angelman Syndrome (AS).  ... study will examine if the off label administration ... with Angelman Syndrome. Minocycline, an FDA approved antibiotic, is ...
... Feb. 14, 2012  Milo Biotechnology will receive $250,000 ... assistance and some capital into early stage Northeast ... a therapy to increase muscle strength and improve ... Milo is the 61st company in JumpStart,s portfolio. ...
... Gen-Probe Incorporated (NASDAQ: GPRO ) today reported ... in the quarter grew 16%, to a new record of ... to a new high of $0.72. "Gen-Probe finished ... quarter while clinical diagnostics revenues continued their solid growth," said ...
Cached Biology Technology:Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial 2Foundation for Angelman Syndrome Therapeutics (FAST) Funds Human Clinical Trial 3JumpStart Invests $250,000 in Milo Biotechnology 2Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 2Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 3Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 4Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 5Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 6Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 7Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 8Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 9Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 10Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 11Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 12Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 13Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 14Gen-Probe Reports Financial Results for the Fourth Quarter of 2011 15
Values of steady state parameters for enzyme activities are determined....
... Proliferator-Activated Receptor-gamma (PPAR) is a member ... ligand-activated transcription factors that heterodimerize with ... involved in the regulation of glucose ... (TZD) class of anti-diabetic agents called ...
... Service includes 1. Scanning of gel(s) ... High-sensitive tryptic in-gel digestion and peptide ... MALDI-MS 5. Acquisition of PMF (Peptide ... ultraflex TOF/TOF) 6. Acquisition of PFF ...
... Preparation Reconstitution: one vial contains ... ficoll and 50 mg PVP; ... water yields a 50concentrate Special ... 1.00 g/mL (20 C) Quality ...
Biology Products: